News for Revive Therapeutics Ltd. (RVV.CN)

Revive Therapeutics (RVVTF) advances in the development of a next-generation Bucillamine formulation. FDA Orphan Drug Designation secured for ischemia-r

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (”œRevive” or the ”œCompany”) ( RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life s

**media[600879]**

Revive Therapeutics (RVVTF) to explore Bucillamine's potential in cancer treatment. Partnership with U.S. University Cancer Institute and Defence R&D Ca

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (”œRevive” or the ”œCompany”) ( RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life

**media[582623]**

TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (”œRevive” or the ”œCompany”) ( RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty lif

**media[570934]**

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- TORONTO, March 3, 2025 ”“ Revive Therapeutics Ltd. (”œRevive” or the ”œCompany”) ( RVVTF) (CSE: RVV) (FRANK

**media[531197]**

**media[509214]**

TORONTO, July 02, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life science…

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life science…

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life science…

Corporate Fact Sheet Q2-2024 OVERVIEW Developing novel therapeutics and...

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life…

Corporate Fact Sheet Q1-2024 OVERVIEW Developing novel therapeutics and...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life…